Year on year, we have seen double-digit growth in the number of projects we recruit that include Oncologists. Last year alone we recruited over 700 projects that included Oncologists. The complexity of the research is increasing: longer interview lengths and pre-tasks added to qualitative projects and a higher number of chart pull exercises on the quantitative side, are just a few examples. At the same time, Oncologists are telling us they have less and less time for market research in an already stressful day:

Prior to 2012, Reckner was able to complete over 225 Oncologists from our own panel for a single online project and over 300 completed surveys when bringing on a partner. That year, Oncologists began to significantly limit their availability for pharmaceutical sales representative visits. This limitation began to seep into Oncologists' willingness to participate in survey research. The past two years have seen a return to sales rep interactions especially, with the onset of virtual visits. However, the ability to complete the sample sizes of the past has not returned. Why is this and what is so different about the Oncology space for survey research?

This year, we will share with you a series about Oncology where these issues, and more, will be addressed. Tune in next month as we interview Reckner’s very own experts – all of whom have been with us for over 20 years and have experienced the transformation firsthand.

Next month we’ll be talking more about this topic. As always, I’m happy to discuss more with you and learn about your specific needs.

Best,

Michael Georgianna

Account Director

Reckner Healthcare | www.recknerhealthcare.com